Hitachi also signs on as OEM partnerAnalogic's long-awaited mobile CT scanner made its debut in thePhilips booth as Tomoscan SR 3200M at this month's RadiologicalSociety of North America conference. The scanner dovetails withPhilips' plans to
Analogic's long-awaited mobile CT scanner made its debut in thePhilips booth as Tomoscan SR 3200M at this month's RadiologicalSociety of North America conference. The scanner dovetails withPhilips' plans to develop its image-guided surgery program, butalso has features that make it a practical CT system for manyhospitals in the developing world.
The work-in-progress scanner was touted by Philips as a low-costsolution for CT performed during surgery and in the emergencyroom and intensive care unit. The complete system, including gantry,patient couch and operator console, weighs less than 1500 poundsand is built on wheels for easy mobility. The system will fitthrough a standard three-foot-wide doorway and requires less than200 sq. ft. for operation, according to the company.
The scanner operates on less than 1500 watts of common AC orDC power, thus eliminating the need for special wiring. Unlikeconventional CT systems, SR 3200M's patient table is fixed inplace while the continuous rotation gantry moves incrementally.This distinction increases the system's value in scanning traumapatients who may have suffered additional injury by being moved,according to Marc M. Lawrence, Philips' director of CT marketing.The system's compact design and modest power requirements makeit an attractive choice for field military applications, he said.
SR 3200M was designed by Analogic of Peabody, MA, which suppliesCT components to many OEMs. Philips announced at the RSNA meetingthat it will cooperate with Hitachi Medical Systems, its long-standingCT partner, in the clinical testing of the system.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.